Four-year secukinumab treatment outcomes in axial spondyloarthritis and psoriatic arthritis patients treated in routine care: results from the EuroSpA collaboration: results from the EuroSpA collaboration

Marion Pons; Stylianos Georgiadis; Zohra Faizy Ahmadzay; Mikkel Østergaard; Bente Glintborg; Jette Heberg; Sara Nysom  Christiansen; Simon Horskjær Rasmussen; Isabel Castrejón Fernández; Fernando Sánchez-Alonso; Karin Laas; Sigrid Vorobjov; Nikita Khmelinskii; Jakub Závada; Adrian Ciurea; Michael J Nissen; Brigitte Michelsen; Pawel Mielnik; A G Loft; Žiga Rotar; Katja Perdan Pirkmajer; Gary J Macfarlane; Gareth T Jones; Dan Nordstrom; Anna-Mari Hokkanen; Irene van Sder Horst-Bruinsma; Johan Karlsson Wallman; Bjorn Gudbjornsson; Olafur  Palsson; Merete Lund Hetland; Lykke Midtbøll Ørnbjerg

Four-year secukinumab treatment outcomes in axial spondyloarthritis and psoriatic arthritis patients treated in routine care: results from the EuroSpA collaboration: results from the EuroSpA collaboration

Marion Pons, Stylianos Georgiadis, Zohra Faizy Ahmadzay, Mikkel Østergaard, Bente Glintborg, Jette Heberg, Sara Nysom Christiansen, Simon Horskjær Rasmussen, Isabel Castrejón Fernández, Fernando Sánchez-Alonso, Karin Laas, Sigrid Vorobjov, Nikita Khmelinskii, Jakub Závada, Adrian Ciurea, Michael J Nissen, Brigitte Michelsen, Pawel Mielnik, A G Loft, Žiga RotarKatja Perdan Pirkmajer, Gary J Macfarlane, Gareth T Jones, Dan Nordstrom, Anna-Mari Hokkanen, Irene van Sder Horst-Bruinsma, Johan Karlsson Wallman, Bjorn Gudbjornsson, Olafur Palsson, Merete Lund Hetland, Lykke Midtbøll Ørnbjerg

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Publikationsdato	2023
Status	Udgivet - 2023
Begivenhed	ACR Convergence 2023 - San Diego, USA Varighed: 10 nov. 2023 → 15 nov. 2023

Konference

Konference	ACR Convergence 2023
Land/Område	USA
By	San Diego
Periode	10/11/2023 → 15/11/2023

Citationsformater

Pons, M., Georgiadis, S., Ahmadzay, Z. F., Østergaard, M., Glintborg, B., Heberg, J., Christiansen, S. N., Rasmussen, S. H., Castrejón Fernández, I., Sánchez-Alonso, F., Laas, K., Vorobjov, S., Khmelinskii, N., Závada, J., Ciurea, A., Nissen, M. J., Michelsen, B., Mielnik, P., Loft, A. G., ... Ørnbjerg, L. M. (2023). Four-year secukinumab treatment outcomes in axial spondyloarthritis and psoriatic arthritis patients treated in routine care: results from the EuroSpA collaboration: results from the EuroSpA collaboration. Arthritis & Rheumatology, vol. 75, suppl. 9, page 4339. Abstract fra ACR Convergence 2023, San Diego, USA.

Four-year secukinumab treatment outcomes in axial spondyloarthritis and psoriatic arthritis patients treated in routine care: results from the EuroSpA collaboration: results from the EuroSpA collaboration. / Pons, Marion ; Georgiadis, Stylianos ; Ahmadzay, Zohra Faizy et al.
2023. Arthritis & Rheumatology, vol. 75, suppl. 9, page 4339 Abstract fra ACR Convergence 2023, San Diego, USA.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

Pons, M , Georgiadis, S , Ahmadzay, ZF , Østergaard, M , Glintborg, B, Heberg, J, Christiansen, SN, Rasmussen, SH, Castrejón Fernández, I, Sánchez-Alonso, F, Laas, K, Vorobjov, S, Khmelinskii, N, Závada, J, Ciurea, A, Nissen, MJ, Michelsen, B, Mielnik, P, Loft, AG, Rotar, Ž, Pirkmajer, KP, Macfarlane, GJ, Jones, GT, Nordstrom, D, Hokkanen, A-M, van Sder Horst-Bruinsma, I, Wallman, JK, Gudbjornsson, B, Palsson, O, Hetland, ML & Ørnbjerg, LM 2023, 'Four-year secukinumab treatment outcomes in axial spondyloarthritis and psoriatic arthritis patients treated in routine care: results from the EuroSpA collaboration: results from the EuroSpA collaboration', ACR Convergence 2023, San Diego, USA, 10/11/2023 - 15/11/2023 s. Arthritis & Rheumatology, vol. 75, suppl. 9, page 4339.

@conference{23f66b3688ac473892d6ee23bec13824,

title = "Four-year secukinumab treatment outcomes in axial spondyloarthritis and psoriatic arthritis patients treated in routine care: results from the EuroSpA collaboration: results from the EuroSpA collaboration",

author = "Marion Pons and Stylianos Georgiadis and Ahmadzay, {Zohra Faizy} and Mikkel {\O}stergaard and Bente Glintborg and Jette Heberg and Christiansen, {Sara Nysom} and Rasmussen, {Simon Horskj{\ae}r} and {Castrej{\'o}n Fern{\'a}ndez}, Isabel and Fernando S{\'a}nchez-Alonso and Karin Laas and Sigrid Vorobjov and Nikita Khmelinskii and Jakub Z{\'a}vada and Adrian Ciurea and Nissen, {Michael J} and Brigitte Michelsen and Pawel Mielnik and Loft, {A G} and {\v Z}iga Rotar and Pirkmajer, {Katja Perdan} and Macfarlane, {Gary J} and Jones, {Gareth T} and Dan Nordstrom and Anna-Mari Hokkanen and {van Sder Horst-Bruinsma}, Irene and Wallman, {Johan Karlsson} and Bjorn Gudbjornsson and Olafur Palsson and Hetland, {Merete Lund} and {\O}rnbjerg, {Lykke Midtb{\o}ll}",

note = "COPECARE; ACR Convergence 2023 ; Conference date: 10-11-2023 Through 15-11-2023",

year = "2023",

language = "English",

pages = "Arthritis & Rheumatology, vol. 75, suppl. 9, page 4339",

}

TY - ABST

T1 - Four-year secukinumab treatment outcomes in axial spondyloarthritis and psoriatic arthritis patients treated in routine care: results from the EuroSpA collaboration

T2 - ACR Convergence 2023

AU - Pons, Marion

AU - Georgiadis, Stylianos

AU - Ahmadzay, Zohra Faizy

AU - Østergaard, Mikkel

AU - Glintborg, Bente

AU - Heberg, Jette

AU - Christiansen, Sara Nysom

AU - Rasmussen, Simon Horskjær

AU - Castrejón Fernández, Isabel

AU - Sánchez-Alonso, Fernando

AU - Laas, Karin

AU - Vorobjov, Sigrid

AU - Khmelinskii, Nikita

AU - Závada, Jakub

AU - Ciurea, Adrian

AU - Nissen, Michael J

AU - Michelsen, Brigitte

AU - Mielnik, Pawel

AU - Loft, A G

AU - Rotar, Žiga

AU - Pirkmajer, Katja Perdan

AU - Macfarlane, Gary J

AU - Jones, Gareth T

AU - Nordstrom, Dan

AU - Hokkanen, Anna-Mari

AU - van Sder Horst-Bruinsma, Irene

AU - Wallman, Johan Karlsson

AU - Gudbjornsson, Bjorn

AU - Palsson, Olafur

AU - Hetland, Merete Lund

AU - Ørnbjerg, Lykke Midtbøll

N1 - COPECARE

PY - 2023

Y1 - 2023

M3 - Conference abstract for conference

SP - Arthritis & Rheumatology, vol. 75, suppl. 9, page 4339

Y2 - 10 November 2023 through 15 November 2023

ER -